Embecta Corp. (EMBC)
$5.69-1.04%Close
BUYRECOVERY · day 18
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $338M
- Beta
- 0.83
- Div yield
- 5.38%
- P/E (TTM)
- 3.99
- Short % float
- 9.99%
- Days to cover
- 5.4
- SI change
- +5.0%
- 1W
- +0.71%
- 1M
- +16.36%
- vs SPY 1W
- -0.45%
- vs SPY 1M
- +13.37%
Industry peers
FMP comparable companies · ranked by market cap
- CDNABUYCareDx, Inc$3.5BBULLQ 18$67.15+2.35%
- MRVIBUYMaravai LifeSciences Holdings, Inc.$2.2BCRISISQ -1$7.90+3.19%
- VIRBUYVir Biotechnology, Inc.$1.9BBULLQ 13$11.17+5.22%
- PSNLSELLPersonalis, Inc.$1.7BRECOVERYQ 6$16.28-0.37%
- AQSTSELLAquestive Therapeutics, Inc.$571MRECOVERYQ -4$4.55+0.42%
- PRMEBUYPrime Medicine, Inc.$538MRECOVERYQ -6$2.98+11.45%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 24
- VALUE
- 28
- GROWTH
- 60
- GARP
- 4
- TYPE
- Dividend Compounder
Composite of Value · Growth · GARP
ROIC-8.4%
REV YoY-
ROE-14.0%
EPS YoY-
ROA6.9%
GROSS60
OP25
NET9
[VALUATION]
P/E TTM3.99
P/E FWD3.82
SECTOR PE20.47
INDUSTRY PE45.68
P/B-0.57
P/FCF-
EV/EBITDA5.99
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO1.68
ND/EBITDA-
BETA0.83